search
Back to results

Remote Monitoring of Patients With CHF in Central Greece (RHCluster7GR)

Primary Purpose

Congestive Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Home telemonitoring of patients with CHF
Sponsored by
Regional Health Authority of Sterea & Thessaly
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Congestive Heart Failure focused on measuring Congestive Heart Failure, Telemedicine

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 65 years.
  • Discharge from hospital after acute heart failure in the previous 3 months and FE < 40% or FE > 40% plus BNP > 400 (or plus NT-proBNP>1500) during hospitalization

Exclusion Criteria:

  • Comorbidities prevalent on CHF with life expectation < 12 months.
  • Inability to use the equipment and help at home not available.
  • Myocardial infarction or percutaneous coronary intervention in the last 3 months.
  • Coronary artery bypass, valve substitution or correction in the last 6 months or scheduled.
  • Being on waiting list for heart transplantation.
  • Being enrolled in other trial.

Sites / Locations

  • Cardiology Department - Regional University Hospital of Larisa

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual Care

Home telemonitoring of patients with CHF

Arm Description

Patients in the control group receive usual care delivered by their primary care physicians and cardiologists. Usual care consists of regular visits to the specialist or primary care clinics every time a medication change is required, or a medical examination is needed.

Outcomes

Primary Outcome Measures

Combined end point of all cause mortality
Number of hospitalisations for heart failure

Secondary Outcome Measures

Cardiovascular and all-cause mortality
Health related quality of life as measured by the SF-36 v2
Patient's specific activity using Specific activity questionnaire (SAQ) and the Veterans specific activity questionnaire (VSAQ)
Disease Specific Quality of Life using the Minnesota Living with Heart Failure questionnaire (MLHF)
Economic Evaluation (Cost-Effective Analysis- Cost Utility Analysis)
Patients' Acceptance-Satisfaction measured by the WSD Questionnaire

Full Information

First Posted
January 2, 2012
Last Updated
March 19, 2015
Sponsor
Regional Health Authority of Sterea & Thessaly
Collaborators
Ministry for Health and Social Solidarity, Greece, Municipality of Trikala, Greece, Institute of Biomedical Research & Technology, Larissa, Greece, Institute of Communications and Computer Systems, Athens, Greece, Alexander Technological Educational Institute, Thessaloniki, Greece, University of Macedonia, Thessaloniki, Greece, University of Thessaly
search

1. Study Identification

Unique Protocol Identification Number
NCT01503463
Brief Title
Remote Monitoring of Patients With CHF in Central Greece
Acronym
RHCluster7GR
Official Title
Renewing Health RCT for the Evaluation of Remote Monitoring of Patients With Congestive Heart Failure (CHF) in Central Greece
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
January 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Regional Health Authority of Sterea & Thessaly
Collaborators
Ministry for Health and Social Solidarity, Greece, Municipality of Trikala, Greece, Institute of Biomedical Research & Technology, Larissa, Greece, Institute of Communications and Computer Systems, Athens, Greece, Alexander Technological Educational Institute, Thessaloniki, Greece, University of Macedonia, Thessaloniki, Greece, University of Thessaly

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate whether telemonitoring of patients with chronic heart failure produces a reduction in the combined end point of all cause mortality and number of hospitalisations, and whether it improves health related quality of life. In addition, the trials evaluate the economic and organisational impact of the telemonitoring service and examine its acceptability by patients and health professionals.
Detailed Description
The purpose of this study is to the evaluate the use of a mobile and PSTN phone-based telehealth platform will be able to produce a reduction in the combined end point of all cause mortality, will have positive or negative impact in their generic and disease specific quality of life , or their specific activity compared with usual care. Following this; it is also hypothesized that this will also lead to a change in overall risk for CHF complications. In addition the patients' satisfaction using the telemedicine service will be studied. A Cost-Effective Analysis and Cost Utility Analysis will evaluate the tele-health service compared with the usual care from the health and social perspective.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congestive Heart Failure
Keywords
Congestive Heart Failure, Telemedicine

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Patients in the control group receive usual care delivered by their primary care physicians and cardiologists. Usual care consists of regular visits to the specialist or primary care clinics every time a medication change is required, or a medical examination is needed.
Arm Title
Home telemonitoring of patients with CHF
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Home telemonitoring of patients with CHF
Intervention Description
Patients in the intervention group receive a personal 1-lead or 12-lead ECG recorder, a blood pressure monitor, a digital weight scale and appropriate education regarding the use of these devices. ThA trained nurse visits the patients weekly during the first month, and monthly thereafter, to confirm the appropriate use of the devices and services, to monitor symptoms, adherence to pharmacological and non-pharmacological treatment, and to complete the case record forms when necessary. If there is deterioration in the monitored vital signs, or if symptoms are reported, the allocated cardiologist is informed via the telehealth platform and has to decide whether the patient has to visit the hospital as in- or outpatient and whether the therapy has to be modified.
Primary Outcome Measure Information:
Title
Combined end point of all cause mortality
Time Frame
12 months minimum
Title
Number of hospitalisations for heart failure
Time Frame
12 months minimum
Secondary Outcome Measure Information:
Title
Cardiovascular and all-cause mortality
Time Frame
12 months minimum
Title
Health related quality of life as measured by the SF-36 v2
Time Frame
12 months minimum- at the entry point of the intervention and the end
Title
Patient's specific activity using Specific activity questionnaire (SAQ) and the Veterans specific activity questionnaire (VSAQ)
Time Frame
12 months minimum- at the entry point of the intervention and the end.
Title
Disease Specific Quality of Life using the Minnesota Living with Heart Failure questionnaire (MLHF)
Time Frame
12 months minimum- at the entry point of the intervention and the end.
Title
Economic Evaluation (Cost-Effective Analysis- Cost Utility Analysis)
Time Frame
12 months minimum
Title
Patients' Acceptance-Satisfaction measured by the WSD Questionnaire
Time Frame
at 2nd and at 12th month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 65 years. Discharge from hospital after acute heart failure in the previous 3 months and FE < 40% or FE > 40% plus BNP > 400 (or plus NT-proBNP>1500) during hospitalization Exclusion Criteria: Comorbidities prevalent on CHF with life expectation < 12 months. Inability to use the equipment and help at home not available. Myocardial infarction or percutaneous coronary intervention in the last 3 months. Coronary artery bypass, valve substitution or correction in the last 6 months or scheduled. Being on waiting list for heart transplantation. Being enrolled in other trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Filippos Triposkiadis, MD, PhD
Organizational Affiliation
Cardiology Department - Regional University Hospital of Larisa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cardiology Department - Regional University Hospital of Larisa
City
Larissa
State/Province
Thessaly
ZIP/Postal Code
41110
Country
Greece

12. IPD Sharing Statement

Citations:
PubMed Identifier
19687005
Citation
Scherr D, Kastner P, Kollmann A, Hallas A, Auer J, Krappinger H, Schuchlenz H, Stark G, Grander W, Jakl G, Schreier G, Fruhwald FM; MOBITEL Investigators. Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. J Med Internet Res. 2009 Aug 17;11(3):e34. doi: 10.2196/jmir.1252.
Results Reference
background
PubMed Identifier
17426062
Citation
Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007 May 5;334(7600):942. doi: 10.1136/bmj.39156.536968.55. Epub 2007 Apr 10.
Results Reference
background
PubMed Identifier
15893183
Citation
Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH; TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 2005 May 17;45(10):1654-64. doi: 10.1016/j.jacc.2005.01.050. Epub 2005 Apr 22.
Results Reference
background
PubMed Identifier
19850208
Citation
Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009 Oct 27;54(18):1683-94. doi: 10.1016/j.jacc.2009.08.017. Erratum In: J Am Coll Cardiol. 2010 May 11;55(19):2185.
Results Reference
background
PubMed Identifier
20687083
Citation
Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JG. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007228. doi: 10.1002/14651858.CD007228.pub2.
Results Reference
background
PubMed Identifier
21733889
Citation
Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail. 2011 Sep;13(9):1028-40. doi: 10.1093/eurjhf/hfr039. Epub 2011 Jul 6.
Results Reference
background
PubMed Identifier
21080835
Citation
Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Engl J Med. 2010 Dec 9;363(24):2301-9. doi: 10.1056/NEJMoa1010029. Epub 2010 Nov 16. Erratum In: N Engl J Med. 2011 Feb 3;364(5):490. N Engl J Med. 2013 Nov 7;369(19):1869.
Results Reference
background
Links:
URL
http://www.renewinghealth.eu/
Description
"The Renewing Health project is partially funded under the ICT Policy Support Programme (ICT PSP) as part of the Competitiveness and Innovation Framework Programme by the European Community"

Learn more about this trial

Remote Monitoring of Patients With CHF in Central Greece

We'll reach out to this number within 24 hrs